Global Regenerative Medicine Market to Reach US$6.5 bn by 2019, Propelled by Increasing Demand for Tissue Engineering and Stem Cell Therapy

Regenerative medicine is considered as an emerging field of medical science that aims to regenerate, repair or replace damaged tissue and organs. The U.S. National Institutes of Health defines regenerative medicine as the process of creating functional tissues to replace and repair organ or tissue damaged due to congenital defects, age, or disease. Regenerative medicines boast wide-ranging applications in neurology, cardiovascular, musculoskeletal, and orthopedic diseases and ailments.

The report studies the global regenerative medicine market from ground-up covering the market definition, segmentation on the basis of various parameters, and factors influencing its growth trajectory. To present a granular analysis, the global regenerative medicine market is segmented on the basis of technology, by application, and regionally.

The market study enumerates the various advancements impacting the regenerative medicine market, and incorporates in-depth study on its competitive landscape by profiling the prominent enterprises. To present valuable insights pertaining to the market’s growth metrics, the report includes Porter’s five forces analysis, market attractiveness analysis, and key players’ analysis.

Overview of Global Regenerative Medicine Market

The latest technologies introduced in tissue engineering and stem cell therapy are anticipated to give a significant impetus to the global regenerative medicine (bone and joint) market. In addition, the rising incidence of joint disorders and bone injuries has also considerably aided the expansion of the global market for regenerative medicine. However, the market faces challenges from stringent regulatory compliance, risk of post implantation rejection, and ethical issues related to stem cell therapy. Nevertheless, the global regenerative medicine market, which in 2012 stood at US$2.59 bn, will reach US$6.47 bn by the end of 2019, exhibiting a CAGR of 12.8% between 2012 and 2019.

Based on technology, the market is segmented into stem cell therapy, tissue, engineering, and biomaterials. In terms of application the global regenerative medicine market is segmented into bone graft substitute, autogenic bones, allogeneic bones, osteoarticular diseases, and others.

Brochure Download: http://bit.ly/1MxBXnL

Regionally, the market is segmented into Asia Pacific, Europe, North America, and Rest of the World. Of these, North America accounted for the largest share in the global regenerative medicine market in 2012 due to the escalating demand for bone and joint reconstructive surgeries. Favorable government initiatives in the region have also supported the growth of the regenerative medicine market in North America. Europe emerged as the second largest regional market for regenerative medicine in 2012. Asia Pacific also exhibits impressive growth prospects for the regenerative medicine market. The region is likely to exhibit the highest CAGR between 2013 and 2019.

Companies mentioned in the research report

The most prominent companies profiled in the report are Anika Therapeutics, Inc., CONMED Corporation, Arthrex, Inc., DePuy Synthes, Inc., Baxter International, Inc., Medtronic, Inc., Stryker Corporation, Smith & Nephew PLC, and Zimmer Holdings, Inc. These enterprises are studied based on aspects such as company overview, business strategies, financial overview, recent developments, and product portfolio.

The global regenerative medicine (bone and joint) market is segmented as follows:

Regenerative Medicine (Bone and Joint) Market, by Technology

-Stem Cell Therapy
-Biomaterial
-Tissue Engineering

Regenerative Medicine (Bone and Joint) Market, by Application

-Bone Graft Substitutes
-Osteoarticular Diseases
-Allogeneic Bones
-Autogenic Bones
-Others

Browse Full Research Report: http://bit.ly/1ZHXZWS

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR’s data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact Us

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.